Athenex
is a biopharmaceutical company that develops novel immune cell therapies for the treatment of cancer and inflammatory diseases... Read moreAthenex
is a biopharmaceutical company that develops novel immune cell therapies for the treatment of cancer and inflammatory diseases... Read more
News
May 17, 2023
The Business Journals
Athenex: Athenex to lay off 123 WNY employees, close both Buffalo-area plants by mid-August
May 15, 2023
ABF Journal
Athenex: Athenex Reaches Agreement with Lenders to Pursue Expedited Sales Process
May 15, 2023
Benzinga
Athenex: Athenex Voluntarily Filed For Chapter 11 Proceedings, Shares Plunge
May 15, 2023
The Business Journals: Buffalo Business First
Athenex: Athenex files for bankruptcy, announces plans to sell assets
May 01, 2023
StreetInsider
Press Release: Athenex : Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-SPY2 TRIAL at ASCO
Apr 26, 2023
The Business Journals
Athenex: Athenex appoints chief restructuring officer 'to serve and create value for its stakeholders'
Apr 17, 2023
The Business Journals: Buffalo Business First
Athenex: California-based Biomed Industries offers to buy Athenex
Apr 13, 2023
PR-Inside
Press Release: Athenex : Biomed Industries, Inc. Offers to Buy Athenex, Inc.
Mar 20, 2023
Owler
Athenex, Inc.: Athenex's revenue changed from $121.80M in Sep 2022 to $102.82M in Dec 2022
Mar 20, 2023
BioSpace
Athenex: Athenex Provides Fourth Quarter and Full Year 2022 Financial Results and Business Update
